Sawai Group Holdings Co., Ltd. Logo

Sawai Group Holdings Co., Ltd.

4887.T

(2.2)
Stock Price

1.881,50 JPY

7.29% ROA

12.06% ROE

3.66x PER

Market Cap.

282.195.591.917,00 JPY

42.63% DER

4.24% Yield

13.68% NPM

Sawai Group Holdings Co., Ltd. Stock Analysis

Sawai Group Holdings Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sawai Group Holdings Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (38%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

The stock's ROE falls within an average range (6.26%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (3.7%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

4 PBV

The stock's PBV ratio (1.12x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

6 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

7 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

8 Dividend

Investors can rely on the company's consistent dividend payments over the past three years, offering a steady stream of returns.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-18.944) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Sawai Group Holdings Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sawai Group Holdings Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Sawai Group Holdings Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sawai Group Holdings Co., Ltd. Revenue
Year Revenue Growth
2012 80.502.000.000
2013 89.823.000.000 10.38%
2014 105.454.000.000 14.82%
2015 123.492.000.000 14.61%
2016 132.392.000.000 6.72%
2017 168.068.000.000 21.23%
2018 184.341.000.000 8.83%
2019 182.537.000.000 -0.99%
2020 187.219.000.000 2.5%
2021 193.816.000.000 3.4%
2022 200.344.000.000 3.26%
2023 215.200.000.000 6.9%
2023 176.862.000.000 -21.68%
2024 177.312.000.000 0.25%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sawai Group Holdings Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2012 4.550.000.000
2013 5.170.000.000 11.99%
2014 6.109.000.000 15.37%
2015 8.019.000.000 23.82%
2016 7.238.000.000 -10.79%
2017 14.533.000.000 50.2%
2018 16.671.000.000 12.82%
2019 13.487.000.000 -23.61%
2020 13.883.000.000 2.85%
2021 24.413.000.000 43.13%
2022 16.090.000.000 -51.73%
2023 13.696.000.000 -17.48%
2023 12.189.000.000 -12.36%
2024 9.408.000.000 -29.56%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sawai Group Holdings Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 13.824.000.000
2013 14.567.000.000 5.1%
2014 15.801.000.000 7.81%
2015 17.532.000.000 9.87%
2016 18.381.000.000 4.62%
2017 26.652.000.000 31.03%
2018 0 0%
2019 0 0%
2020 0 0%
2021 46.690.000.000 100%
2022 30.156.000.000 -54.83%
2023 31.020.000.000 2.79%
2023 23.244.000.000 -33.45%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sawai Group Holdings Co., Ltd. EBITDA
Year EBITDA Growth
2012 21.151.000.000
2013 24.080.000.000 12.16%
2014 26.552.000.000 9.31%
2015 30.229.000.000 12.16%
2016 31.867.000.000 5.14%
2017 36.415.000.000 12.49%
2018 42.128.000.000 13.56%
2019 44.592.000.000 5.53%
2020 36.905.000.000 -20.83%
2021 -18.698.000.000 297.37%
2022 34.879.000.000 153.61%
2023 42.888.000.000 18.67%
2023 36.941.000.000 -16.1%
2024 38.240.000.000 3.4%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sawai Group Holdings Co., Ltd. Gross Profit
Year Gross Profit Growth
2012 37.992.000.000
2013 41.471.000.000 8.39%
2014 45.407.000.000 8.67%
2015 50.809.000.000 10.63%
2016 50.922.000.000 0.22%
2017 65.195.000.000 21.89%
2018 74.899.000.000 12.96%
2019 73.500.000.000 -1.9%
2020 72.434.000.000 -1.47%
2021 66.652.000.000 -8.67%
2022 62.633.000.000 -6.42%
2023 68.400.000.000 8.43%
2023 54.319.000.000 -25.92%
2024 56.028.000.000 3.05%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sawai Group Holdings Co., Ltd. Net Profit
Year Net Profit Growth
2012 12.022.000.000
2013 12.192.000.000 1.39%
2014 14.053.000.000 13.24%
2015 17.155.000.000 18.08%
2016 17.969.000.000 4.53%
2017 14.017.000.000 -28.19%
2018 19.376.000.000 27.66%
2019 19.279.000.000 -0.5%
2020 12.340.000.000 -56.23%
2021 -28.269.000.000 143.65%
2022 12.667.000.000 323.17%
2023 19.704.000.000 35.71%
2023 13.695.000.000 -43.88%
2024 61.944.000.000 77.89%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sawai Group Holdings Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 318
2013 330 3.64%
2014 382 13.39%
2015 466 18.06%
2016 487 4.52%
2017 360 -35.28%
2018 443 18.55%
2019 440 -0.45%
2020 282 -56.58%
2021 -646 143.57%
2022 289 323.18%
2023 450 35.63%
2023 313 -43.91%
2024 1.414 77.93%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sawai Group Holdings Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2012 8.252.000.000
2013 6.401.000.000 -28.92%
2014 -184.000.000 3578.8%
2015 2.200.000.000 108.36%
2016 4.432.000.000 50.36%
2017 11.666.000.000 62.01%
2018 32.216.000.000 63.79%
2019 12.083.000.000 -166.62%
2020 10.733.000.000 -12.58%
2021 10.966.000.000 2.12%
2022 -14.115.000.000 177.69%
2023 -1.500.000.000 -841%
2023 3.558.000.000 142.16%
2024 -14.538.000.000 124.47%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sawai Group Holdings Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2012 12.255.000.000
2013 13.422.000.000 8.69%
2014 12.112.000.000 -10.82%
2015 19.975.000.000 39.36%
2016 23.270.000.000 14.16%
2017 28.472.000.000 18.27%
2018 42.924.000.000 33.67%
2019 30.256.000.000 -41.87%
2020 31.857.000.000 5.03%
2021 34.310.000.000 7.15%
2022 13.026.000.000 -163.4%
2023 23.149.000.000 43.73%
2023 7.614.000.000 -204.03%
2024 -1.888.000.000 503.28%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sawai Group Holdings Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2012 4.003.000.000
2013 7.021.000.000 42.99%
2014 12.296.000.000 42.9%
2015 17.775.000.000 30.82%
2016 18.838.000.000 5.64%
2017 16.806.000.000 -12.09%
2018 10.708.000.000 -56.95%
2019 18.173.000.000 41.08%
2020 21.124.000.000 13.97%
2021 23.344.000.000 9.51%
2022 27.141.000.000 13.99%
2023 24.649.000.000 -10.11%
2023 4.056.000.000 -507.72%
2024 12.650.000.000 67.94%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sawai Group Holdings Co., Ltd. Equity
Year Equity Growth
2012 61.477.000.000
2013 101.300.000.000 39.31%
2014 112.397.000.000 9.87%
2015 125.720.000.000 10.6%
2016 141.237.000.000 10.99%
2017 202.441.000.000 30.23%
2018 223.204.000.000 9.3%
2019 233.686.000.000 4.49%
2020 240.750.000.000 2.93%
2021 200.083.000.000 -20.33%
2022 212.738.000.000 5.95%
2023 226.454.000.000 6.06%
2023 218.030.000.000 -3.86%
2024 213.893.000.000 -1.93%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sawai Group Holdings Co., Ltd. Assets
Year Assets Growth
2012 127.842.000.000
2013 149.348.000.000 14.4%
2014 166.179.000.000 10.13%
2015 206.492.000.000 19.52%
2016 225.609.000.000 8.47%
2017 358.453.000.000 37.06%
2018 372.889.000.000 3.87%
2019 384.814.000.000 3.1%
2020 393.341.000.000 2.17%
2021 349.502.000.000 -12.54%
2022 364.165.000.000 4.03%
2023 397.727.000.000 8.44%
2023 382.024.000.000 -4.11%
2024 372.890.000.000 -2.45%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sawai Group Holdings Co., Ltd. Liabilities
Year Liabilities Growth
2012 66.365.000.000
2013 48.048.000.000 -38.12%
2014 53.782.000.000 10.66%
2015 80.772.000.000 33.42%
2016 84.372.000.000 4.27%
2017 156.011.000.000 45.92%
2018 149.683.000.000 -4.23%
2019 151.128.000.000 0.96%
2020 152.591.000.000 0.96%
2021 149.419.000.000 -2.12%
2022 151.427.000.000 1.33%
2023 171.273.000.000 11.59%
2023 163.994.000.000 -4.44%
2024 158.997.000.000 -3.14%

Sawai Group Holdings Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4282.72
Net Income per Share
585.87
Price to Earning Ratio
3.66x
Price To Sales Ratio
1.5x
POCF Ratio
5.03
PFCF Ratio
-74.91
Price to Book Ratio
0.44
EV to Sales
1.69
EV Over EBITDA
8.54
EV to Operating CashFlow
17
EV to FreeCashFlow
-84.39
Earnings Yield
0.27
FreeCashFlow Yield
-0.01
Market Cap
282,20 Bil.
Enterprise Value
317,90 Bil.
Graham Number
8023.06
Graham NetNet
-217.79

Income Statement Metrics

Net Income per Share
585.87
Income Quality
1.31
ROE
0.12
Return On Assets
0.07
Return On Capital Employed
0.07
Net Income per EBT
1.32
EBT Per Ebit
0.97
Ebit per Revenue
0.11
Effective Tax Rate
0.33

Margins

Sales, General, & Administrative to Revenue
0.1
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.31
Operating Profit Margin
0.11
Pretax Profit Margin
0.1
Net Profit Margin
0.14

Dividends

Dividend Yield
0.04
Dividend Yield %
4.24
Payout Ratio
0.22
Dividend Per Share
91

Operating Metrics

Operating Cashflow per Share
426.87
Free CashFlow per Share
-86
Capex to Operating CashFlow
1.2
Capex to Revenue
0.12
Capex to Depreciation
1.32
Return on Invested Capital
0.04
Return on Tangible Assets
0.07
Days Sales Outstanding
107.44
Days Payables Outstanding
140.7
Days of Inventory on Hand
296.77
Receivables Turnover
3.4
Payables Turnover
2.59
Inventory Turnover
1.23
Capex per Share
512.86

Balance Sheet

Cash per Share
1.266,35
Book Value per Share
4.883,07
Tangible Book Value per Share
4409.68
Shareholders Equity per Share
4883.07
Interest Debt per Share
2096.96
Debt to Equity
0.43
Debt to Assets
0.24
Net Debt to EBITDA
0.96
Current Ratio
3.04
Tangible Asset Value
193,16 Bil.
Net Current Asset Value
59,89 Bil.
Invested Capital
283924000000
Working Capital
146,88 Bil.
Intangibles to Total Assets
0.06
Average Receivables
56,21 Bil.
Average Payables
47,74 Bil.
Average Inventory
102574000000
Debt to Market Cap
0.32

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sawai Group Holdings Co., Ltd. Dividends
Year Dividends Growth
2021 65
2022 130 50%
2023 130 0%
2024 299 56.38%
2025 0 0%

Sawai Group Holdings Co., Ltd. Profile

About Sawai Group Holdings Co., Ltd.

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States. It offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, urogenital organs and the anus, antineoplastic, vitamins, anti-cancer, chemotherapeutic agents, respiratory organ agents, hormone agents, etc. The company's products include atorvastatin, limaprost alfadex, lansoprazole, aprepitant, micafungin sodium, silodosin, blonanserin, oseltamivir, capecitabine, atomoxetine hydrochloride, nalfurafine, memantine hydrochloride, eldecalcitol, bazedoxifene, fexofenadine hydrochloride, dutasteride, pregabalin, duloxetine hydrochloride, morphine sulfate tablets, tosymra nasal spray, zembrace symtouch, and ramelteon tablets. It also manufactures and sells medicinal products. The company sells its generic drugs to distributors, retail stores, and other pharmaceutical manufacturers, as well as directly to medical institutions, such as hospitals, general practitioners, and dispensing pharmacies in Japan; and pharmaceutical products to wholesalers in the United States. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.

CEO
Mr. Mitsuo Sawai
Employee
3.482
Address
5-2-30, Miyahara
Osaka, 532-0003

Sawai Group Holdings Co., Ltd. Executives & BODs

Sawai Group Holdings Co., Ltd. Executives & BODs
# Name Age
1 Mr. Shoji Yokota Ph.D.
Senior Managing Executive Officer, Group Chief Research & Development Officer and Director
70
2 Ms. Nobuko Sugimoto
Group Chief Intellectual Property Officer
70
3 Jun Tsujii
General Manager of the Group Finance Department
70
4 Mr. Toshiya Hasuo
Group Chief Production Officer
70
5 Mr. Toru Terashima
Senior Executive Officer
70
6 Mr. Motohiko Kimura
Senior Managing Executive Officer
70
7 Mr. Mitsuo Sawai
Chairman, President, Group Chief Executive Officer & Group Chief Operating Officer
70
8 Mr. Yasushi Kora
General Manager of Public Relations & Investor Relations Office
70
9 Mr. Kazuhiko Sueyoshi
Deputy Group Chief Executive Officer
70
10 Mr. Seiji Nishimura
Corporate Officer & Group Chief Marketing Officer
70

Sawai Group Holdings Co., Ltd. Competitors